Ibgard®, a Novel Small Intestine Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in Severe and Unbearable IBS Symptom Intensity. Results From a US Based, 4-Week, Randomized, Placebo-Controlled, Multi-Center Ibsrest™ Trial

被引：0

|

作者：

Cash, Brooks D.

Epstein, Michael S.

Shah, Syed M.

机构：

来源：

GASTROENTEROLOGY | 2015年 / 148卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Su1373

引用

收藏

页码：S489 / S489

页数：1

相关论文

共 3 条

[1] Ibgard®, a Novel Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in the Total IBS Symptom Score and Individual IBS Symptoms. Results From the US Based, 4-Week, Randomized, Placebo Controlled, Multi-Centered Ibsrest™ Trial
Cash, Brooks D.
Epstein, Michael S.
Shah, Syed M.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S662 - S663
[2] 24-Hour Results From a Placebo-Controlled Trial, to Evaluate a Novel Peppermint Oil Delivery System, Targeting Release in the Small Intestine. Results From the US Based, 4-Week, Randomized, Placebo Controlled, Multi-Centered Ibsrest™ Trial
Epstein, Michael S.
Cash, Brooks D.
Shah, Syed M.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S69 - S70
[3] IBS Is a Syndrome of Inter-Related Symptoms. the Cause Is Multi-Factorial and Its Epicenter Is the Small Intestine. A US Based, Placebo-Controlled Trial Shows That PO's Targeted Delivery Provides Significant Improvement in the Syndrome of Symptoms
Epstein, Michael S.
Cash, Brooks D.
Shah, Syed M.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S488 - S489